Stay updated on Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial

Sign up to get notified when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Version bumped from v3.4.2 to v3.4.3; no visible changes to the study page content or layout.
    Difference
    0.1%
    Check dated 2026-03-11T16:27:32.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added, and the lapse-in-funding notice and Revision: v3.4.1 were removed. The study details and page content remain unchanged.
    Difference
    0.4%
    Check dated 2026-02-11T10:17:05.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH Clinical Center status was added, and the site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:57:29.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The updates are limited to UI/text changes and page revision metadata (e.g., Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) with no changes to the underlying study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:59:44.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision changed from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T03:25:09.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a 'Locations' section showing Maryland as a study location. Removed the 'Maryland Locations' entry and the 'HHS Vulnerability Disclosure' footer link.
    Difference
    0.2%
    Check dated 2025-12-23T22:48:25.000Z thumbnail image

Stay in the know with updates to Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy Neoadjuvant/Adjuvant Pancreatic AdenoClinicalTrial page.